Secondary Hyperoxaluria
4 clinical trials · Condition
◉ Watch Secondary Hyperoxaluria
| Record | Firm | Date |
|---|---|---|
| Lanthanum Carbonate (Fosrenol®) to Reduce Oxalate Excretion in Patients With Secondary Hyperoxaluria and Nephrolithiasis (NCT03346369) | Universitair Ziekenhuis Brussel | 2017-08-18 |
| A Pilot Study of Oxalate Absorption in Secondary Hyperoxaluria (NCT03095885) | Allena Pharmaceuticals | 2016-11-01 |
| Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Secondary Hyperoxaluria and Kidney Stones Over 28 Days (NCT02547805) | Allena Pharmaceuticals | 2015-09-01 |
Track Secondary Hyperoxaluria automatically
Every clearance here is in the API, with alerts when new ones post.